"Work Disrupted by a Barrage of Protests"... Mounting Tensions on the Frontlines of the Drug Delivery Dispute

Government Announces Expansion of Prescription Drug Delivery with Telemedicine Reform
No Meetings Held Even a Month After Official Declaration
Pharmacist Associations Voice Concerns Over Potential Misuse
Sharp Division Persists Between Phar

Conflicts and tensions are erupting in the field even before discussions between the government and relevant parties regarding the expansion of telemedicine and the institutionalization of medicine delivery services have begun in earnest. This is due to the ongoing differences in stance between the platform industry, which is calling for dialogue through a public-private consultative body, and pharmacy organizations, which are opposing the expansion of medicine delivery services.

According to related industries and government sources on September 30, it has been more than a month since the Ministry of Health and Welfare officially announced the full-scale expansion of medicine delivery in line with the institutionalization of telemedicine scheduled for December. However, the pan-government public-private consultative body meant to discuss these issues has not even held its first meeting, nor has it established a related schedule.

Previously, on August 20, the government announced the formation of a pan-governmental public-private consultative body, including the Office for Government Policy Coordination, the Ministry of Health and Welfare, the Ministry of SMEs and Startups, pharmacy organizations, and businesses involved in telemedicine. The purpose was to discuss the expansion of delivery services for all telemedicine patients, the structure of the pharmaceutical distribution market, and the role of platforms. This reflects the government's view that medicine delivery extends beyond the realm of the medical system to include issues such as platform and new industry regulation and regulatory reform.

Meanwhile, in the field, there are growing moves to attack or pressure the opposing side depending on interests. So far, the attacks from pharmacy organizations toward the platform industry have been especially prominent. An official from the platform industry said, "We are receiving a flood of protest calls to our related groups and companies. People are demanding to know the reasoning behind our position, or pressing to find out who is behind certain statements." The official also lamented, "We are spending so much time answering phone calls that it is disrupting our work. The language is so rough and aggressive that it is difficult to respond properly." Recently, there was even an incident where a threatening message implying a bomb had been placed at telemedicine platform DoctorNow prompted a police and fire department response, underscoring the heightened sense of tension in the industry.

Pharmacy organizations, represented by the Korean Pharmaceutical Association, strongly oppose the expansion of delivery services, arguing that, unlike ordinary goods, medications require specific expertise in preparation, medication counseling, storage, and quality management, and that expanding delivery could increase medical shopping or misuse and abuse of pharmaceuticals. They also point out the concern that if private platforms connect the process from consultation to prescription, selection of pharmacies, and delivery, it may cause patients to be concentrated at certain pharmacies and make local pharmacies dependent on platforms. On the other hand, the platform industry maintains that concerns can be alleviated by separating pharmacists' roles in preparation and medication guidance from the platform's function as an intermediary, and by putting restrictions in place to prevent any particular pharmacy from being favored or solicited. The government is currently reviewing secondary legislation to establish a delivery system centered on neighborhood pharmacies, prohibiting exclusive telemedicine pharmacies.

With conflict and interests this sharply divided, the public-private consultative body proposed by the government remains at a standstill. The platform industry is insisting, "Let's sit down at the table and start by discussing safety standards," while the pharmacists' association maintains a negative position toward any discussion premised on expanding delivery services. There are prospects that it may take a considerable amount of time before any meaningful dialogue can proceed. A government official commented, "Since we need to find a way to ensure both patient convenience and safety, it is meaningless to proceed without the involvement of pharmacy organizations. Relevant ministries must first discuss among themselves and seek ways to persuade stakeholders, and while it may be a drawn-out process, it is a task we must undertake even if immediate resolution is difficult."

This content was produced with the assistance of AI translation services.